Johnson & Johnson 🇺🇸
JNJ • Financials • USA
💡 Institutional Quantitative Investment Thesis
High-quality compounder passing 6/9 fundamental checks. Strong balance sheet with Forward PER compression (23.7x vs 40.0x) and robust Free Cash Flow generation.
📊 Frequently Asked Questions & Related Moat Stocks
1. What is Johnson & Johnson (JNJ)'s Economic Moat Score in 2026?
In 2026, Johnson & Johnson (JNJ) holds a proprietary MoatPicks Economic Moat Score™ of 87.0/100 (Wide Economic Moat). This 12-point fundamental audit evaluates JNJ's 67.8% gross margin, $18.5B free cash flow generation, +5.9% YoY revenue growth, and 1.3x Debt/EBITDA ratio. You can benchmark any stock's competitive durability interactively with our Economic Moat Score™ Checker.
2. Is JNJ stock undervalued right now based on P/E and PEG ratio?
Johnson & Johnson (JNJ) trades near fair institutional value with a Forward P/E of 23.7x and a PEG ratio of 1.32x, supported by +5.9% YoY revenue growth. At a share price of $263.81, investors can stress-test JNJ's fair value using the MoatPicks Economic Moat Score™ Checker and FIRE compounding calculators. Model how compounding JNJ fits your long-term retirement target in our FIRE Financial Independence Calculator.
3. Which superinvestors and 13F hedge funds own JNJ stock?
Johnson & Johnson (JNJ) is actively monitored across our 25 tracked 13F superinvestor portfolios and institutional quality screens. Institutional capital focuses on JNJ's 67.8% gross margin, $18.5B free cash flow, and 1.3x Debt/EBITDA balance sheet.